Using Kaplan-Meier-plotter (33), we observed that the tissue expression values of the 28-gene signature had the ability to predict the clinical outcomes of all subtypes of BC patients (Figure 5A), as well as ER positive patients (Figure 5B), basal-like patients (Figure 5C) and clinical stage III patients (Figure 5D). Here, ESR1 is linked to breast cancer.